Comparison of the effect of heparin, reteplase and taurolock in the prevention of thrombosis in hemodialysis catheters

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220103053614N1

Enrollment

185

Registered

2022-01-30

Start date

2021-11-09

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombosis in dialysis catheters.

Interventions

Intervention 1: Intervention group: Injection of high dose heparin (1000 units) plus 2 cc of distilled water to the number of dialysis patients per week in both lines of hemodialysis catheter. Interve

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Dialysis patients with catheter (premict) Patient satisfaction

Exclusion criteria

Exclusion criteria: No premix catheter for dialysis Mentioning the history of allergies to the intervened drugs Lack of awareness to obtain satisfaction

Design outcomes

Primary

Measure	Time frame
Thrombosis in dialysis catheters. Timepoint: At the beginning of the study and six months after the intervention. Method of measurement: Successful full dialysis during routine dialysis sessions.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactazadeh razian

Khoram-Abad University of Medical Sciences

azadeh.r697@yahoo.com+98 66 3324 3965

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026